Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results
16.01.2015 16:12
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Ad hoc report in accordance with Sec. 15 of the German Securities Trading
Act
Drägerwerk AG & Co. KGaA: Dräger exceeds forecast thanks to strong
end-of-year business
In fiscal year 2014, Drägerwerk AG & Co. KGaA generated an EBIT margin of
up to 7.5 percent on the basis of preliminary figures (2013: 8.5 percent).
Previously, the EBIT margin was forecast at between 4.5 percent and 6.5
percent. Net sales rose by around 2.5 percent year on year to EUR 2,434
million. Dräger experienced a 1.4 percent rise in order intake, meaning
that orders on hand as of December 31 are down year on year. Net of
currency effects, net sales growth came to roughly 3.9 percent and order
intake growth approximately 3.0 percent.
The main reasons for the stronger than anticipated development in earnings
were strong net sales performance in end-of-year business, good pricing
performance and a slightly lower than expected cost base. Net sales and
earnings benefited from purchases pulled forward due to the rise in
value-added tax on medical devices in Spain.
In fiscal year 2015, the recent fall in the value of the euro compared to
the U.S. dollar is set to have a negative impact on earnings due to our
high U.S. dollar cost base. In sum, the cost base will be above the 2014
level due to, among other factors, higher investments into Research and
Development.
Against this backdrop, Dräger expects net sales in fiscal year 2015 (net of
currency effects) to grow at or slightly below the level of 2014. The EBIT
margin will probably fall compared to 2014 levels.
A more detailed annual forecast will be provided once the audited figures
for fiscal year 2014 are announced on March 11, 2015.
The aforementioned estimates of net sales and margin performance are based
on the assumption of stable development in markets relevant to Dräger and
unchanged foreign exchange rates.
Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck, Germany
www.draeger.com
Investor Relations:
Thomas Fischler
Phone: +49 451 882-2685
thomas.fischler@draeger.com
Corporate Communications:
Melanie Kamann
Phone: +49 451 882-3998
melanie.kamann@draeger.com
Disclaimer
This ad hoc report contains statements on the future development of Dräger
Group. These forward-looking statements are based on the current
expectations, presumptions, and forecasts of the Executive Board as well as
the information available to date. They were compiled to the best of the
company's knowledge. Dräger does not provide any warranty nor assume any
responsibility for the future developments and results described above.
These are dependent on a number of factors. They entail various risks and
contingencies outside of the company's influence and are based on
assumptions which could prove to be incorrect. Dräger does not assume any
responsibility for updating the forward-looking statements contained in
this report. This does not infringe any legal stipulations on the
adjustment of forecasts. Please go to Investor Relations / Financial
Calendar at www.draeger.com for information on all important financial
dates.
16.01.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23542 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: info@draeger.com
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555
067 7, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067
Genussschein K, 555071 Genussschein D
Indices: TecDAX
Listed: Regulierter Markt in Berlin, Düsseldorf, Frankfurt (Prime
Standard), Hamburg, Hannover, München; Freiverkehr in
Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: Drägerwerk AG & Co. KGaA: Dräger exceeds forecast thanks to strong end-of-year business
| Source: EQS Group AG